Navigation Links
Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
Date:4/4/2011

ompared to +9.1% for the placebo group.

"In this study, QNEXA patients on the top dose had sustained weight loss greater than 10% over two years. This weight loss led to clinically relevant reductions in blood pressure, triglyceride reduction greater than 25%, and a dramatic increase in HDL levels," stated Dr. Davidson. "Achieving and maintaining this degree of weight loss, one that impacts cardiovascular risk in a clinically meaningful way, is often difficult for patients. Maintaining double-digit weight loss over two years, with resulting improvements in cardiovascular risk factors and an overall reduction in medications used to treat comorbidities makes this important data for clinicians."  

QNEXA therapy was well tolerated, with no new safety signals seen between 56 and 108 weeks. The most common side effects were upper respiratory infection, constipation, tingling, sinus infection, dry mouth and runny nose. Serious adverse event rates over two years were low (mid and top dose 5.9%, 8.1%) and placebo (6.2%), with no drug-related serious adverse events reported. The completion rate in SEQUEL was approximately 83% for both QNEXA doses and 86% for the placebo group. Discontinuations due to adverse events were 4.6% and 4.4% for the mid and top dose, respectively, and 3.1% for the placebo group.

About the SEQUEL Study

SEQUEL (OB-305) was a double-blind, placebo-controlled, three-arm, prospective study. Patients continued receiving the same treatment assignment to which they had been randomized in the CONQUER study in a blinded fashion: either once-daily treatment with top-dose QNEXA (n=295), mid-dose QNEXA (n=153), or placebo (n=227). The SEQUEL study was a 52-week extension study for a subset of patients who completed the 56-week CONQUER study. The total study period was 108 weeks. SEQUEL included 675 obese or overweight patients, all of whom had two or more weight-related co-morbidities and an average baseli
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
2. Medizone Internationals Mass-Market Sterilization Technology to be Produced by Canadian Medical Device Heavyweights
3. The Spatz Adjustable Balloon System® for Weight Loss Becomes the First Intragastric Balloon to Receive Regulatory Approval for 1 Year Implantation Time
4. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
5. New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
6. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
7. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
8. The Results are in: Users of BodyMedias Wearable Body-Monitoring Technology Lose 3 Times More Weight
9. ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
10. Womens Digital Imaging Using DXA Total Body Fat Analysis to Help Patients in Weight Management and Fitness Programs
11. New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015 Velos, Inc., the pioneering software ... grow and add customers who receive Clinical and Translational ... CTSAs awarded by the National Institutes of Health currently ... is among the largest such market shares in its ... CTSA community keeps growing as a result of our ...
(Date:6/30/2015)... , June 30, 2015   Millar, Inc. ... technology, today announced the 2016 retirement of Craig ... Directors, after 12 years of service to the Company. ... named two senior members of the Executive Management team ... Tim Daugherty , currently Director of Sales and ...
(Date:6/30/2015)... , June 30, 2015 Olympus, ... innovative solutions for medical and surgical procedures, among ... next-day replacements for surgical equipment at no additional ... to offer this type of guarantee. The service ... Service Agreement earlier this year. ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... 7, 2010 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Review meeting with the U.S. Food and Drug Administration (FDA) ... the Company,s New Drug Application (NDA) for AZ-004 ( Staccato ... FDA in preparation for the meeting, with the responses or ...
... Dec. 7, 2010 Apexigen, Inc. announced today ... worldwide license agreement with Centocor Research & Development, ... therapeutic antibody technologies to discover and develop monoclonal ... to several targets specified by Centocor R&D, which ...
Cached Medicine Technology:Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 2Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 3Apexigen, Inc. Announces Collaboration for Antibody Discovery 2
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable source of ... native of Detroit, MI, Kid Rock, is hitting the road again this summer in what ... and hip hop superstar kicked off his summer tour this year at the XFINITY Theatre ...
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
Breaking Medicine News(10 mins):Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... ... at ITEXPO , ... CA, ITEXPO West 2009 (PRWEB) September 3, 2009 -- FaxBack®, a leading provider of ... program for a new fax ATA device, based on HTTPS, which provides a superior level ...
... ... , ... September 3, 2009 -- Today,s challenging business environment requires companies to maximize valuable resources ... staffs, the reliance on outside consultants to accomplish these strategies becomes not just a ...
... , , PHOENIX, Sept. 2 ... southwestern United States, has formed a strategic alliance with American National ... getting claims compensated in a timely manner with a proprietary process ... , , "Over the last 10 years ...
... MONTREAL, Sept. 2 With five years and ... manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of ... products nationwide in Canada with an exclusive multimillion-dollar agreement ... Patterson has operations in Vancouver, Edmonton, Calgary, London, Toronto, ...
... , , , ... Martek Biosciences Corporation (Nasdaq: MATK ) today announced its financial results ... $77.8 million, down 12% from $88.4 million in the third quarter of fiscal ... third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or ...
... , NEW YORK , Sept. 2 In the ... don,t have to shout to be heard. A pioneer in the eHealth ... online call for a careful, strategic approach to reform is attracting the ... as everyday Americans currently struggling to pay their medical bills. , ...
Cached Medicine News:Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 3Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Martek Announces Third Quarter 2009 Financial Results 2Health News:Martek Announces Third Quarter 2009 Financial Results 3Health News:Martek Announces Third Quarter 2009 Financial Results 4Health News:Martek Announces Third Quarter 2009 Financial Results 5Health News:Martek Announces Third Quarter 2009 Financial Results 6Health News:Martek Announces Third Quarter 2009 Financial Results 7Health News:Martek Announces Third Quarter 2009 Financial Results 8Health News:Martek Announces Third Quarter 2009 Financial Results 9Health News:Martek Announces Third Quarter 2009 Financial Results 10Health News:Martek Announces Third Quarter 2009 Financial Results 11Health News:Martek Announces Third Quarter 2009 Financial Results 12Health News:Healthcare Debate: One Citizen's Call for Calm Catches On 2
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: